Developer docs
API playgroundTry for free, no card

Search company profiles

fasteris

Full company profile

uuid000lcnp

Namestring
fasteris
Legal namestring
Genesupport SA
Websiteurl
fasteris.com
Company typeenum
Private
Founded yearint
2003
Descriptiontext

Fasteris is the commercial brand of Genesupport SA, a Swiss biotechnology company headquartered in Plan-les-Ouates, Geneva. Founded in 2003, the company operates a laboratory service business focused on next-generation sequencing (NGS) and Sanger sequencing for life science researchers, biotechnology companies, and clinical laboratories. Its customer base spans academic research groups, biotech drug discovery and development programs, and healthcare/clinical laboratory customers needing precision medicine and diagnostic-grade sequencing.

The company's service portfolio is organized across two technology stacks — NGS and Sanger — with NGS offerings covering Ready-to-Run Sequencing, RNA-sequencing (RNA-seq), DNA-sequencing (DNA-Seq), Whole Exome Sequencing (WES), and Custom Projects. Sequencing is performed on Illumina and Ion Torrent platforms, and the workflow is extended by two ancillary modules: Extraction services for sample preparation and Bioinformatics services for both standard and custom computational analysis of NGS data. Fasteris claims early-pioneer positioning in NGS technology and holds patents (filed/pending) related to sequencing methods and workflows under the Genesupport umbrella.

Commercially, Fasteris operates a fee-for-service, project-based laboratory services model. Customers submit biological samples via a dedicated sample shipment portal, and pricing is provided on a quote basis rather than published rates. The go-to-market is sales-led and emphasizes scientific credibility through publications, presentations, conferences, press coverage, and customer newsletters rather than digital or paid acquisition. The company operates as a subsidiary of the privately held Swiss parent Genesupport, with no disclosed external funding, M&A activity, or public listing.

Short descriptiontext

Fasteris is the commercial brand of Swiss biotech Genesupport SA, providing next-generation sequencing and Sanger sequencing laboratory services to academic researchers, biotech companies, and clinical laboratories from its Plan-les-Ouates, Geneva facility.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersPlan-les-ouates, Switzerland
HQ citystring
Plan-les-ouates
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
DNA sequencing services, next-generation sequencing, Sanger sequencing, bioinformatics analysis, genomic laboratory services
Industry4 codes
PRIMARYHLAGANAA
Genomics & Next-Generation Sequencing (NGS) Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGANAE
Transcriptomics & Gene Expression Profiling Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
SIC code2 codes
  • Services-Medical Laboratories8071
  • Services-Testing Laboratories8734
Product category
Genomic Sequencing Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Laboratory Sequencing Services
TypeProfessional Services
Description

Fee-for-service laboratory operations providing NGS and Sanger sequencing services to life science researchers and biotech companies. Revenue generated through project-based service contracts where customers submit biological samples for sequencing and analysis.

fasteris.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Fasteris is a Swiss laboratory service provider that runs customer biological samples through next-generation sequencing (NGS) on Illumina and Ion Torrent platforms and Sanger sequencing instruments, then returns sequence data and/or processed bioinformatics results. Its service portfolio spans standard ready-to-run sequencing, RNA-seq, DNA-seq, whole exome sequencing, custom NGS projects, Sanger standard and custom services, with supporting extraction and bioinformatics analysis as part of an end-to-end workflow.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Fasteris operates as a LifeScience provider offering a unified portfolio of sequencing services organized around two primary technology platforms: NGS (Next-Generation Sequencing) and Sanger sequencing. The NGS offering includes Ready-to-Run Sequencing, RNA-sequencing, DNA-sequencing, and Whole Exome Sequencing as core sequencing services, supplemented by Custom projects for bespoke study designs. Two supporting add-on modules—Bioinformatics services and Extraction services—provide end-to-end workflow capability from sample preparation through data analysis. The Sanger branch provides Standard and Custom DNA sequencing services for validation applications. The company positions itself as a pioneer in NGS technology, serving primarily life science and biotech research clients through its Swiss-based operations.

Product and service9 records
1Ready-to-Run Sequencing
CategoryNGS sequencing service
Description

Pre-configured sequencing service providing rapid turnaround on Illumina and Ion Torrent platforms for standardized genomic analysis workflows, targeted at researchers needing fast, standardized NGS results.

2RNA-sequencing (RNA-seq)
CategoryNGS sequencing service
Description

Comprehensive RNA sequencing service enabling gene expression profiling and transcriptomic analysis on Illumina sequencing platforms, targeted at researchers running gene expression and transcriptome studies.

3DNA-sequencing (DNA-Seq)
CategoryNGS sequencing service
Description

DNA sequencing service covering a range of biological queries including whole genome and targeted sequencing approaches, used by researchers for general genomic analysis.

4Whole Exome Sequencing (WES)
CategoryNGS sequencing service
Description

Targeted exome sequencing service that captures and sequences all protein-coding regions of the genome to support variant discovery studies, used by clinical and translational researchers.

5Custom projects
CategoryNGS sequencing service
Description

Tailored NGS solutions for ad-hoc studies requiring non-standard experimental designs or specialized analysis workflows, used by researchers and biotech teams with bespoke sequencing needs.

6Bioinformatics services
CategoryBioinformatics analysis service
Description

Computational analysis services supporting both standard pipelines and custom bioinformatics workflows for NGS data interpretation, used by researchers needing expert analysis of sequencing outputs.

7Extraction services
CategorySample preparation service
Description

DNA and RNA extraction services that prepare high-quality biological samples for downstream sequencing applications, used by researchers submitting samples for sequencing.

8Sanger Standard Services
CategorySanger sequencing service
Description

Standard DNA Sanger sequencing services for routine validation and confirmation of genetic sequences, used by researchers for low-throughput verification work.

9Sanger Custom Services
CategorySanger sequencing service
Description

Customized DNA Sanger sequencing solutions for specialized validation requirements outside standard service parameters, used when standard Sanger workflows do not fit the project.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Korea-headquartered genomics services company offering Sanger, NGS, and bioinformatics with European operations. Competes head-to-head with Fasteris for academic and biotech sequencing projects, particularly for European and international clients.

TypeDirect peer
Description

Now part of Azenta, GENEWIZ is a global genomics services provider with strong Sanger and NGS offerings, bioinformatics, and direct customer submission portals that closely mirror Fasteris' service model.

TypeBroad incumbent
Description

One of the world's largest genomics service providers with NGS, WGS, and clinical sequencing capacity. Competes with Fasteris for large international projects while also operating proprietary platforms (e.g., DNBSEQ), giving it strategic independence Fasteris lacks.

TypeRegional player
Description

Swiss-based DNA sequencing and synthesis services provider headquartered near Fasteris. A direct regional competitor in Sanger and NGS services, sharing the Swiss quality reputation and overlapping academic/biotech customer base in Switzerland and nearby markets.

5CeGaT
TypeDirect peer
Description

Tübingen-based German provider of clinical and research NGS services, including WES, WGS, RNA-seq, and bioinformatics interpretation. A near-twin to Fasteris in service mix and European clinical/research orientation, with similar mid-sized scale.

TypeBroad incumbent
Description

Subsidiary of Eurofins Scientific, offering a broad portfolio of sequencing, genotyping, and oligo services across Europe and globally. Overlaps directly with Fasteris but benefits from group-scale infrastructure and a much wider commercial footprint.

TypeDirect peer
Description

Global NGS service provider offering DNA-seq, RNA-seq, WES, WGS, and bioinformatics on Illumina platforms. Closest direct competitor to Fasteris in fee-for-service genomics, but at significantly larger scale and broader geographic reach.

TypeBroad incumbent
Description

Dominant NGS instrument vendor whose sequencing services and Connected Software extend into service-provider territory. Not a primary competitor today, but its platform decisions shape Fasteris' product roadmap and could expand downstream into services.

TypeDirect peer
Description

Berlin-based genomics services company offering DNA-seq, RNA-seq, WES, and bioinformatics for academic and clinical customers. Direct competitor in the DACH/European region with a comparable boutique service profile.

TypeBroad incumbent
Description

Genomics services and products arm of LGC Group, providing sequencing, genotyping, and custom oligonucleotide services. Broader portfolio than Fasteris but overlapping in NGS and Sanger sequencing offerings for life science customers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks2 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

fasteris

Genomic Sequencing Servicesfasteris.com

Fasteris is the commercial brand of Swiss biotech Genesupport SA, providing next-generation sequencing and Sanger sequencing laboratory services to academic researchers, biotech companies, and clinical laboratories from its Plan-les-Ouates, Geneva facility.

What fasteris does

Fasteris is the commercial brand of Genesupport SA, a Swiss biotechnology company headquartered in Plan-les-Ouates, Geneva. Founded in 2003, the company operates a laboratory service business focused on next-generation sequencing (NGS) and Sanger sequencing for life science researchers, biotechnology companies, and clinical laboratories. Its customer base spans academic research groups, biotech drug discovery and development programs, and healthcare/clinical laboratory customers needing precision medicine and diagnostic-grade sequencing.

The company's service portfolio is organized across two technology stacks — NGS and Sanger — with NGS offerings covering Ready-to-Run Sequencing, RNA-sequencing (RNA-seq), DNA-sequencing (DNA-Seq), Whole Exome Sequencing (WES), and Custom Projects. Sequencing is performed on Illumina and Ion Torrent platforms, and the workflow is extended by two ancillary modules: Extraction services for sample preparation and Bioinformatics services for both standard and custom computational analysis of NGS data. Fasteris claims early-pioneer positioning in NGS technology and holds patents (filed/pending) related to sequencing methods and workflows under the Genesupport umbrella.

Commercially, Fasteris operates a fee-for-service, project-based laboratory services model. Customers submit biological samples via a dedicated sample shipment portal, and pricing is provided on a quote basis rather than published rates. The go-to-market is sales-led and emphasizes scientific credibility through publications, presentations, conferences, press coverage, and customer newsletters rather than digital or paid acquisition. The company operates as a subsidiary of the privately held Swiss parent Genesupport, with no disclosed external funding, M&A activity, or public listing.

fasteris firmographics

Firmographics
Name
fasteris
Legal name
Genesupport SA
Website
https://fasteris.com
Company type
Private
Founded year
2003
Operating status
Operating
Headcount range
1–10 employees
Short description
Fasteris is the commercial brand of Swiss biotech Genesupport SA, providing next-generation sequencing and Sanger sequencing laboratory services to academic researchers, biotech companies, and clinical laboratories from its Plan-les-Ouates, Geneva facility.
Ownership category
akta.pro rank

fasteris industry classification

Industry
Product category
Genomic Sequencing Services
SIC
Services-Medical Laboratories (8071), Services-Testing Laboratories (8734)
akta.pro industry
PRIMARYHLAGANAA
Genomics & Next-Generation Sequencing (NGS) Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGANAE
Transcriptomics & Gene Expression Profiling Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)

Keywords

  • DNA sequencing services
  • Next-generation sequencing
  • Sanger sequencing
  • Bioinformatics analysis
  • Genomic laboratory services

Where fasteris is headquartered

Location

Headquarters

HQ city
Plan-les-ouates
HQ country
Switzerland
HQ region
Europe

Offices1 record

Markets served

fasteris business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Laboratory Sequencing Services: Fee-for-service laboratory operations providing NGS and Sanger sequencing services to life science researchers and biotech companies. Revenue generated through project-based service contracts where customers submit biological samples for sequencing and analysis.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

fasteris product offering

Product offering

Core offering

Fasteris is a Swiss laboratory service provider that runs customer biological samples through next-generation sequencing (NGS) on Illumina and Ion Torrent platforms and Sanger sequencing instruments, then returns sequence data and/or processed bioinformatics results. Its service portfolio spans standard ready-to-run sequencing, RNA-seq, DNA-seq, whole exome sequencing, custom NGS projects, Sanger standard and custom services, with supporting extraction and bioinformatics analysis as part of an end-to-end workflow.

Product overview

Fasteris operates as a LifeScience provider offering a unified portfolio of sequencing services organized around two primary technology platforms: NGS (Next-Generation Sequencing) and Sanger sequencing. The NGS offering includes Ready-to-Run Sequencing, RNA-sequencing, DNA-sequencing, and Whole Exome Sequencing as core sequencing services, supplemented by Custom projects for bespoke study designs. Two supporting add-on modules—Bioinformatics services and Extraction services—provide end-to-end workflow capability from sample preparation through data analysis. The Sanger branch provides Standard and Custom DNA sequencing services for validation applications. The company positions itself as a pioneer in NGS technology, serving primarily life science and biotech research clients through its Swiss-based operations.

Differentiator

Problem solved

Functional benefit

Products and services

  • Ready-to-Run Sequencing Pre-configured sequencing service providing rapid turnaround on Illumina and Ion Torrent platforms for standardized genomic analysis workflows, targeted at researchers needing fast, standardized NGS results.
  • RNA-sequencing (RNA-seq) Comprehensive RNA sequencing service enabling gene expression profiling and transcriptomic analysis on Illumina sequencing platforms, targeted at researchers running gene expression and transcriptome studies.
  • DNA-sequencing (DNA-Seq) DNA sequencing service covering a range of biological queries including whole genome and targeted sequencing approaches, used by researchers for general genomic analysis.
  • Whole Exome Sequencing (WES) Targeted exome sequencing service that captures and sequences all protein-coding regions of the genome to support variant discovery studies, used by clinical and translational researchers.
  • Custom projects Tailored NGS solutions for ad-hoc studies requiring non-standard experimental designs or specialized analysis workflows, used by researchers and biotech teams with bespoke sequencing needs.
  • Bioinformatics services Computational analysis services supporting both standard pipelines and custom bioinformatics workflows for NGS data interpretation, used by researchers needing expert analysis of sequencing outputs.
  • Extraction services DNA and RNA extraction services that prepare high-quality biological samples for downstream sequencing applications, used by researchers submitting samples for sequencing.
  • Sanger Standard Services Standard DNA Sanger sequencing services for routine validation and confirmation of genetic sequences, used by researchers for low-throughput verification work.
  • Sanger Custom Services Customized DNA Sanger sequencing solutions for specialized validation requirements outside standard service parameters, used when standard Sanger workflows do not fit the project.

Companies that use fasteris

Customer profile

Segments3 records

Ideal customer profiles3 records

fasteris technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

fasteris partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

fasteris competitors and assessment

Company assessment

Direct peers

  • Macrogen: Korea-headquartered genomics services company offering Sanger, NGS, and bioinformatics with European operations. Competes head-to-head with Fasteris for academic and biotech sequencing projects, particularly for European and international clients.
  • GENEWIZ (Azenta Life Sciences): Now part of Azenta, GENEWIZ is a global genomics services provider with strong Sanger and NGS offerings, bioinformatics, and direct customer submission portals that closely mirror Fasteris' service model.
  • CeGaT: Tübingen-based German provider of clinical and research NGS services, including WES, WGS, RNA-seq, and bioinformatics interpretation. A near-twin to Fasteris in service mix and European clinical/research orientation, with similar mid-sized scale.
  • Novogene: Global NGS service provider offering DNA-seq, RNA-seq, WES, WGS, and bioinformatics on Illumina platforms. Closest direct competitor to Fasteris in fee-for-service genomics, but at significantly larger scale and broader geographic reach.
  • Atlas Biolabs: Berlin-based genomics services company offering DNA-seq, RNA-seq, WES, and bioinformatics for academic and clinical customers. Direct competitor in the DACH/European region with a comparable boutique service profile.

Broad incumbents

  • BGI Genomics: One of the world's largest genomics service providers with NGS, WGS, and clinical sequencing capacity. Competes with Fasteris for large international projects while also operating proprietary platforms (e.g., DNBSEQ), giving it strategic independence Fasteris lacks.
  • Eurofins Genomics: Subsidiary of Eurofins Scientific, offering a broad portfolio of sequencing, genotyping, and oligo services across Europe and globally. Overlaps directly with Fasteris but benefits from group-scale infrastructure and a much wider commercial footprint.
  • Illumina (Services): Dominant NGS instrument vendor whose sequencing services and Connected Software extend into service-provider territory. Not a primary competitor today, but its platform decisions shape Fasteris' product roadmap and could expand downstream into services.
  • LGC Biosearch Technologies: Genomics services and products arm of LGC Group, providing sequencing, genotyping, and custom oligonucleotide services. Broader portfolio than Fasteris but overlapping in NGS and Sanger sequencing offerings for life science customers.

Regional players

  • Microsynth: Swiss-based DNA sequencing and synthesis services provider headquartered near Fasteris. A direct regional competitor in Sanger and NGS services, sharing the Swiss quality reputation and overlapping academic/biotech customer base in Switzerland and nearby markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks2 records

Key highlights6 records

Customer concentration

fasteris social profiles

Digital presence

fasteris financial estimates

Financial estimate

Revenue estimate

Valuation estimate

fasteris leadership team

Management profile

Number of profiles

fasteris funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

fasteris M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about fasteris

What does fasteris do?

Fasteris is a Swiss laboratory service provider that runs customer biological samples through next-generation sequencing (NGS) on Illumina and Ion Torrent platforms and Sanger sequencing instruments, then returns sequence data and/or processed bioinformatics results. Its service portfolio spans standard ready-to-run sequencing, RNA-seq, DNA-seq, whole exome sequencing, custom NGS projects, Sanger standard and custom services, with supporting extraction and bioinformatics analysis as part of an end-to-end workflow.

Is fasteris a public or private company?

fasteris is a private company. It is classified as corporate owned and is currently operating.

When was fasteris founded?

fasteris was founded in 2003. It employs 1 to 10 people.

Where is fasteris based?

fasteris is headquartered in Plan-les-ouates, Switzerland, in the Europe region.

How does fasteris make money?

One revenue line is on record: laboratory Sequencing Services.

Who are fasteris's main competitors?

Direct peers on record are Macrogen, GENEWIZ (Azenta Life Sciences), CeGaT, Novogene and Atlas Biolabs. Broad incumbents are BGI Genomics, Eurofins Genomics, Illumina (Services) and LGC Biosearch Technologies. Microsynth is listed as a regional player.

Does fasteris have an API?

No public API is recorded for fasteris.

What industry is fasteris in?

fasteris's product category is Genomic Sequencing Services. Its primary akta.pro industry code is HLAGANAA, Genomics & Next-Generation Sequencing (NGS) Services, with a secondary code of HLAGANAE, Transcriptomics & Gene Expression Profiling Services. Its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales